1. Home
  2. WVE vs KN Comparison

WVE vs KN Comparison

Compare WVE & KN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

N/A

Current Price

$13.25

Market Cap

2.4B

Sector

Health Care

ML Signal

N/A

Logo Knowles Corporation

KN

Knowles Corporation

N/A

Current Price

$25.09

Market Cap

2.0B

ML Signal

N/A

Company Overview

Basic Information
Metric
WVE
KN
Founded
2012
1946
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Consumer Electronics/Appliances
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2015
2013

Fundamental Metrics

Financial Performance
Metric
WVE
KN
Price
$13.25
$25.09
Analyst Decision
Strong Buy
Buy
Analyst Count
15
3
Target Price
$30.87
$22.33
AVG Volume (30 Days)
2.2M
629.0K
Earning Date
05-29-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
118.94
EPS
N/A
0.50
Revenue
$3,704,000.00
$593,200,000.00
Revenue This Year
N/A
$9.40
Revenue Next Year
$119.93
$6.98
P/E Ratio
N/A
$49.64
Revenue Growth
149.43
7.17
52 Week Low
$5.28
$12.19
52 Week High
$21.73
$28.74

Technical Indicators

Market Signals
Indicator
WVE
KN
Relative Strength Index (RSI) 47.06 41.88
Support Level $12.53 $23.81
Resistance Level $14.56 $25.33
Average True Range (ATR) 0.79 0.85
MACD -0.04 -0.43
Stochastic Oscillator 26.10 24.85

Price Performance

Historical Comparison
WVE
KN

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About KN Knowles Corporation

Knowles Corp is engaged in the manufacturing of micro-acoustic microphones and balanced armature speakers, audio solutions, high-performance capacitors, and radio frequency filtering products. It operates in two segments; the Precision Devices segment specializes in the design and delivery of high-performance capacitor products and RF solutions; and Medtech & Specialty Audio segment designs and manufactures microphones and balanced armature speakers used in applications. The majority of its revenue comes from the Precision Devices. Geographically, it operates in United States, Asia, Other Americas, Europe and Others, out of which United States generates maximum revenue.

Share on Social Networks: